Table 1 Demographic and clinical characteristics of nAMD patients and controls.

From: Alterations in Circulating Immune Cells in Neovascular Age-Related Macular Degeneration

 

All (n= 129)

Controls (n= 26)

nAMD (n= 103)

P value nAMD vs Control

Age (median (range)), years

79.1 (53–94)

76.7 (59–92)

79.5 (53–94)

0.0651

Female sex (number (%))

70 (54)

12 (46)

58 (56)

0.3852

Have history of AMD (number (%))

30 (23)

5 (19)

25 (24)

0.7962

Have history of cardiovascular disease (number (%))

29 (22)

7 (27)

22 (21)

0.6012

Have history of hypertension (number (%))

75 (58)

17 (65)

58 (56)

0.5062

Have history of diabetes (number (%))

15 (12)

2 (8)

13 (13)

0.7342

Body Mass Index (mean ± SD)

26.4 (4.9)

27.1 (5.6)

26.1 (4.7)

0.3973

Smoking status

   

0.6332

Non-smoker (number (%))

52 (40)

11 (42)

41 (40)

 

Former smoker (number (%))

66 (51)

14 (54)

52 (50)

 

Current smoker (number (%))

11 (9)

1 (4)

10 (10)

 

Taking cardiovascular medication (number (%))

90 (87)

19 (73)

71 (69)

0.8132

Taking vitamins (number (%))

25 (19)

2 (8)

23 (22)

0.1042

Taking low-dose aspirin (number (%))

41(32)

4 (15)

37 (36)

0.0592

  1. SD: Standard deviation.
  2. 1Mann Whitney U test.
  3. 2Pearson’s chi-square test.
  4. 3Independent samples t-test.